about
HIV infection, hypercoagulability and ischaemic stroke in adults at the University Teaching Hospital in Zambia: a case control studyPediatric stroke in an African country.Chronic central nervous system expression of HIV-1 Tat leads to accelerated rarefaction of neocortical capillaries and loss of red blood cell velocity heterogeneity.Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.Effect of cocaine on human immunodeficiency virus-mediated pulmonary endothelial and smooth muscle dysfunction.HIV infection and stroke: current perspectives and future directionsIncreased Risk of Intracerebral Hemorrhage Among Patients With Hepatitis C Virus Infection.Association Between Reduced Risk of Intracerebral Hemorrhage and Pelvic Inflammatory DiseasePerinatally HIV-infected youth presenting with acute stroke: progression/evolution of ischemic disease on neuroimaging.[Incidence of strokes in HIV-positive patients treated with long term antiretroviral treatment].Antiretroviral Treatment with Efavirenz Disrupts the Blood-Brain Barrier Integrity and Increases Stroke Severity.Perinatally acquired HIV infection: long-term neuropsychological consequences and challenges ahead.Response of Human Immunodeficiency Virus-Associated Cerebral Angiitis to the Combined Antiretroviral Therapy.Decreased risk of intracerebral hemorrhage among patients with milder allergic rhinitis.Idiopathic massive left ventricular thrombus in HIV patient.Cerebrovascular events in HIV-infected patients: an analysis of a cohort of 3203 HIV+ patients during the times of cART.Outcomes of intravenous tissue plasminogen activator for acute ischaemic stroke in HIV-infected adults.
P2860
Q33707006-2EB64503-44EB-4702-96E2-24BE7638EFFDQ34244385-F3DD93E2-E8B8-465A-9A3C-67AB7A7A0CF5Q34324750-E36401C8-425C-4E9A-A0B7-A964DC5B785FQ35125996-1D842322-D97E-48B1-899C-48F8C68594E3Q35132178-C0281E44-61BD-4D91-AB3E-7CCC5E0AF1A9Q36285922-8F300437-5B50-42C7-989F-ED49A8BE291DQ36299364-23787A3E-9A41-42AF-B7ED-7EA2F4DDC336Q36567022-5E5EDF74-7040-471D-B839-BEF1A99CBFB6Q37051085-E6F8B287-4B75-4322-9388-B4D94AB35D11Q37234864-105F6B6B-DAD1-46FA-BAA9-BDDFF0FE35BEQ37529187-4C335C71-4BE9-4803-8FE8-1566E68FC76FQ38201765-719B6566-A13A-4AE0-A8B8-B6BDD2DAC2ACQ40271158-9CF657AF-985F-4184-87FE-9AE029002B14Q40888304-2A787998-E9EE-4AB2-A469-F48367A7BB34Q41639055-D6E9F5C6-EB9A-4A0D-BAE1-37EB2F31305EQ42197898-D24E1BEC-6891-4EAA-9272-7E0DE6803F46Q48650897-EDB133CA-C578-46DF-8BEA-F718C583BC33
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stroke in HIV infection and AIDS.
@en
Stroke in HIV infection and AIDS.
@nl
type
label
Stroke in HIV infection and AIDS.
@en
Stroke in HIV infection and AIDS.
@nl
prefLabel
Stroke in HIV infection and AIDS.
@en
Stroke in HIV infection and AIDS.
@nl
P2860
P356
P1476
Stroke in HIV infection and AIDS.
@en
P2093
Joseph R Berger
Michael R Dobbs
P2860
P304
P356
10.1586/ERC.09.72
P577
2009-10-01T00:00:00Z